Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Martinez L, Cords O, Horsburgh C, Andrews J, Acuna-Villaorduna C, Desai Ahuja S, Altet N, Augusto O, Baliashvili D, Basu S, Becerra M, Bonnet M, Henry Boom W, Borgdorff M, Boulahbal F, Carvalho A, Cayla J, Chakhaia T, Chan P, Cohen T, Croda J, Datta S, del Corral H, Denholm J, Dietze R, Dobler C, Donkor S, Egere U, Ellner J, Espinal M, Evans C, Fang C, Fielding K, Fox G, García L, García-Basteiro A, Geis S, Graham S, Grandjean L, Hannoun D, Hatherill M, Hauri A, Hesseling A, Hill P, Huang L, Huerga H, Hussain R, Jarlsberg L, Jones-López E, Kato S, Kato-Maeda M, Kampmann B, Kirchner H, Kritski A, Lange C, Lee C, Lee L, Lee M, Lemos A, Lienhardt C, Ling D, Liu Q, Lo N, Long R, Lopez-Varela E, Lu P, Magee M, Malone L, Mandalakas A, Martinson N, Mazahir R, Murray M, Netto E, Otero L, Parsonnet J, Reingold A, Schaaf H, Seddon J, Sharma S, Singh J, Singh S, Sloot R, Sotgiu G, Stein C, Iqbal N, Triasih R, Trieu L, van der Loeff M, Van der Stuyft P, van Schalkwyk C, Vashishtha R, Verhagen L, Villalba J, Wang J, Whalen C, Yoshiyama T, Zar H, Zellweger J, Zhu L. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. The Lancet. ; 395(10228):973-984.
Yaesoubi R, Cohen T. Decision Analytics and Optimization in Disease Prevention and Treatment. ; :59-79.
Ngwatu B, Nsengiyumva N, Oxlade O, Mappin-Kasirer B, Nguyen N, Jaramillo E, Falzon D, Schwartzman K. The impact of digital health technologies on tuberculosis treatment: a systematic review. European Respiratory Journal. ; 51(1):1701596-.
Zimmer C, Yaesoubi R, Cohen T. A Likelihood Approach for Real-Time Calibration of Stochastic Compartmental Epidemic Models. PLOS Computational Biology. ; 13(1):e1005257-.
Abel zur Wiesch P, Clarelli F, Cohen T. Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment Strategies. PLOS Computational Biology. ; 13(1):e1005321-.
Fofana M, Shrestha S, Knight G, Cohen T, White R, Cobelens F, Dowdy D. A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy. ; 61(3):-.
Van Rie A, Cohen T. The contributions of Steve Lawn to the science, advocacy and policy of HIV-associated TB. The International Journal of Tuberculosis and Lung Disease. ; 20(12):1563-1564.
Mears J, Vynnycky E, Lord J, Borgdorff M, Cohen T, Crisp D, Innes J, Lilley M, Maguire H, McHugh T, Woltmann G, Abubakar I, Sonnenberg P. The prospective evaluation of the TB strain typing service in England: a mixed methods study. Thorax. ; 71(8):734-741.
Cohen T, Chindelevitch L, Misra R, Kempner M, Galea J, Moodley P, Wilson D. Within-Host Heterogeneity of. Journal of Infectious Diseases. ; 213(11):1796-1799.
Jezmir J, Cohen T, Zignol M, Nyakan E, Hedt-Gauthier B, Gardner A, Kamle L, Injera W, Carter E. Use of Lot Quality Assurance Sampling to Ascertain Levels of Drug Resistant Tuberculosis in Western Kenya. PLOS ONE. ; 11(5):e0154142-.
Yates T, Khan P, Knight G, Taylor J, McHugh T, Lipman M, White R, Cohen T, Cobelens F, Wood R, Moore D, Abubakar I. The transmission of Mycobacterium tuberculosis in high burden settings. The Lancet Infectious Diseases. ; 16(2):227-238.
Zelner J, Murray M, Becerra M, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Manjourides J, Grenfell B, Cohen T. Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data. Journal of Infectious Diseases. ; 213(2):287-294.
Theron G, Jenkins H, Cobelens F, Abubakar I, Khan A, Cohen T, Dowdy D. Data for action: collection and use of local data to end tuberculosis. The Lancet. ; 386(10010):2324-2333.
Knight G, Colijn C, Shrestha S, Fofana M, Cobelens F, White R, Dowdy D, Cohen T. The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis. Clinical Infectious Diseases. ; 61(suppl 3):S147-S154.
Colijn C, Cohen T. How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance. eLife. ; 4:-.
Birger R, Kouyos R, Cohen T, Griffiths E, Huijben S, Mina M, Volkova V, Grenfell B, Metcalf C. The potential impact of coinfection on antimicrobial chemotherapy and drug resistance. Trends in Microbiology. ; 23(9):537-544.
Kunkel A, Colijn C, Lipsitch M, Cohen T. How could preventive therapy affect the prevalence of drug resistance? Causes and consequences. Philosophical Transactions of the Royal Society B: Biological Sciences. ; 370(1670):20140306-.
Chindelevitch L, Menzies N, Pretorius C, Stover J, Salomon J, Cohen T. Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis. Journal of The Royal Society Interface. ; 12(106):20150146-.
Odone A, Amadasi S, White R, Cohen T, Grant A, Houben R. The Impact of Antiretroviral Therapy on Mortality in HIV Positive People during Tuberculosis Treatment: A Systematic Review and Meta-Analysis. PLoS ONE. ; 9(11):e112017-.
Kouyos R, Metcalf C, Birger R, Klein E, Abel zur Wiesch P, Ankomah P, Arinaminpathy N, Bogich T, Bonhoeffer S, Brower C, Chi-Johnston G, Cohen T, Day T, Greenhouse B, Huijben S, Metlay J, Mideo N, Pollitt L, Read A, Smith D, Standley C, Wale N, Grenfell B. The path of least resistance: aggressive or moderate treatment?. Proceedings of the Royal Society B: Biological Sciences. ; 281(1794):20140566-.
Zwerling A, White R, Vassall A, Cohen T, Dowdy D, Houben R. Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations. PLoS ONE. ; 9(10):e110558-.
Jenkins H, Pagano M, Yuen C, Becerra M, Cohen T. The burden of tuberculosis disease in children–Authors' reply. The Lancet. ; 384(9951):1343-1344.
Cohen T, Jenkins H, Lu C, McLaughlin M, Floyd K, Zignol M. On the spread and control of MDR-TB epidemics: An examination of trends in anti-tuberculosis drug resistance surveillance data. Drug Resistance Updates. ; 17(4-6):105-123.
Dowdy D, Houben R, Cohen T, Pai M, Cobelens F, Vassall A, Menzies N, Gomez G, Langley I, Squire S, White R, for the TB MAC meeting participants. Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling. The International Journal of Tuberculosis and Lung Disease. ; 18(9):1012-1018.
Jenkins H, Tolman A, Yuen C, Parr J, Keshavjee S, Pérez-Vélez C, Pagano M, Becerra M, Cohen T. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. The Lancet. ; 383(9928):1572-1579.
Houben R, Dowdy D, Vassall A, Cohen T, Nicol M, Granich R, Shea J, Eckhoff P, Dye C, Kimerling M, White R. How can mathematical models advance tuberculosis control in high HIV prevalence settings?. The International Journal of Tuberculosis and Lung Disease. ; 18(5):509-514.
Clinical Tuberculosis. ; :-.
Bantubani N, Kabera G, Connolly C, Rustomjee R, Reddy T, Cohen T, Pym A. High Rates of Potentially Infectious Tuberculosis and Multidrug-Resistant Tuberculosis (MDR-TB) among Hospital Inpatients in KwaZulu Natal, South Africa Indicate Risk of Nosocomial Transmission. PLoS ONE. ; 9(3):e90868-.
Pretorius C, Menzies N, Chindelevitch L, Cohen T, Cori A, Eaton J, Fraser C, Gopalappa C, Hallett T, Salomon J, Stover J, White R, Dodd P. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa. AIDS. ; 28:S25-S34.
Huang C, Tchetgen E, Becerra M, Cohen T, Hughes K, Zhang Z, Calderon R, Yataco R, Contreras C, Galea J, Lecca L, Murray M. The Effect of HIV-Related Immunosuppression on the Risk of Tuberculosis Transmission to Household Contacts. Clinical Infectious Diseases. ; 58(6):765-774.
Jenkins H, Plesca V, Ciobanu A, Crudu V, Galusca I, Soltan V, Serbulenco A, Zignol M, Dadu A, Dara M, Cohen T. Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country. European Respiratory Journal. ; 42(5):1291-1301.
Stagg H, Cohen T, Becerra M, Anderson L, Abubakar I. A tale of two settings: the role of the Beijing genotype in the epidemiology of multidrug-resistant tuberculosis. European Respiratory Journal. ; 43(2):632-635.
Robinson K, Fyson N, Cohen T, Fraser C, Colijn C. How the Dynamics and Structure of Sexual Contact Networks Shape Pathogen Phylogenies. PLoS Computational Biology. ; 9(6):e1003105-.
Yaesoubi R, Cohen T. Identifying dynamic tuberculosis case-finding policies for HIV/TB coepidemics. Proceedings of the National Academy of Sciences. ; 110(23):9457-9462.
Lin H, Dowdy D, Dye C, Murray M, Cohen T. The impact of new tuberculosis diagnostics on transmission: why context matters. Bulletin of the World Health Organization. ; 90(10):739-747.
Cohen T, Lin H, Shin S, Jeffery C, Contreras C, Cruz J, Jave O, Yagui M, Asencios L, Pagano M, Manjourides J. Re: Supporting health systems for tuberculosis through research. Tuberculosis. ; 92(4):290-.
Lin H, Shin S, Contreras C, Asencios L, Paciorek C, Cohen T. Use of Spatial Information to Predict Multidrug Resistance in Tuberculosis Patients, Peru. Emerging Infectious Diseases. ; 18(5):811-813.
Robinson K, Cohen T, Colijn C. The dynamics of sexual contact networks: Effects on disease spread and control. Theoretical Population Biology. ; 81(2):89-96.
Lin H, Langley I, Mwenda R, Doulla B, Egwaga S, Millington K, Mann G, Murray M, Squire S, Cohen T. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools [State of the art series. Operational research. Number 8 in the series]. The International Journal of Tuberculosis and Lung Disease. ; 15(8):996-1004.
Cohen T, Corbett E. Test and treat in HIV: success could depend on rapid detection. The Lancet. ; 378(9787):204-206.
Brooks-Pollock E, Becerra M, Goldstein E, Cohen T, Murray M. Epidemiologic Inference From the Distribution of Tuberculosis Cases in Households in Lima, Peru. Journal of Infectious Diseases. ; 203(11):1582-1589.
Colijn C, Cohen T, Ganesh A, Murray M. Spontaneous Emergence of Multiple Drug Resistance in Tuberculosis before and during Therapy. PLoS ONE. ; 6(3):e18327-.
LIN H, SHIN S, BLAYA J, ZHANG Z, CEGIELSKI P, CONTRERAS C, ASENCIOS L, BONILLA C, BAYONA J, PACIOREK C, COHEN T. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiology and Infection. ; 139(11):1784-1793.
Murray M, Cohen T. AIDS and Tuberculosis. ; :253-275.
Lipsitch M, Colijn C, Cohen T, Hanage W, Fraser C. No coexistence for free: Neutral null models for multistrain pathogens. Epidemics. ; 1(1):2-13.
** EXPEDITED REVIEW ** || Adaptive policies to balance health benefits and economic costs of physical distancing interventions during the COVID-19 pandemic. Medical decision making : an international journal of the Society for Medical Decision Making. .
Cohen T, Sommers B, Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect Dis. 2003 Jan;3(1):13-21. doi: 10.1016/s1473-3099(03)00483-3. Review. PubMed PMID: 12505028; NIHMSID:NIHMS94739.
Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, Gopalakrishna G, Chew SK, Tan CC, Samore MH, Fisman D, Murray M. Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003 Jun 20;300(5627):1966-70. doi: 10.1126/science.1086616. Epub 2003 May 23. PubMed PMID: 12766207; PubMed Central PMCID: PMC2760158.
Cohen T, Becerra MC, Murray MB. Isoniazid resistance and the future of drug-resistant tuberculosis. Microb Drug Resist. 2004 Winter;10(4):280-5. doi: 10.1089/mdr.2004.10.280. PubMed PMID: 15650371; PubMed Central PMCID: PMC2652757.
Cohen T, Murray M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med. 2004 Oct;10(10):1117-21. doi: 10.1038/nm1110. Epub 2004 Sep 19. PubMed PMID: 15378056; PubMed Central PMCID: PMC2652755.
What would you like to do?